Detalhe da pesquisa
1.
Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study.
BMC Pulm Med
; 21(1): 253, 2021 Jul 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34332555
2.
Efficacy and safety of the dual bronchodilator combination umeclidinium/vilanterol in COPD by age and airflow limitation severity: A pooled post hoc analysis of seven clinical trials.
Pulm Pharmacol Ther
; 57: 101802, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31096036
3.
Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.
J Am Pharm Assoc (2003)
; 59(4): 479-488.e1, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31126830
4.
Clinical Features of Influenza and Acute Respiratory Illness in Older Adults at Least 50 Years of Age in an Outpatient Setting in the Republic of Korea: a Prospective, Observational, Cohort Study.
J Korean Med Sci
; 32(3): 407-414, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-28145642
5.
Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers.
Proc Natl Acad Sci U S A
; 108(22): 9268-73, 2011 May 31.
Artigo
Inglês
| MEDLINE | ID: mdl-21576462
6.
Brain activity and emotional processing in smokers treated with varenicline.
Addict Biol
; 18(4): 732-8, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21507156
7.
DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers.
Pharmacogenet Genomics
; 22(7): 551-4, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22495174
8.
Nicotine dependence: biology, behavior, and treatment.
Annu Rev Med
; 60: 247-60, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19630572
9.
Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers.
Nicotine Tob Res
; 13(6): 498-503, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-21385908
10.
Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.
Pulm Ther
; 7(1): 203-219, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33728597
11.
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities.
Int J Chron Obstruct Pulmon Dis
; 16: 1149-1161, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33911860
12.
Replication and extension of association of choline acetyltransferase with nicotine dependence in European and African American smokers.
Hum Genet
; 127(6): 691-8, 2010 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-20383528
13.
Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy.
Int J Chron Obstruct Pulmon Dis
; 15: 2715-2725, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33149569
14.
Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting ß2-agonist bronchodilators.
Postgrad Med
; 132(2): 198-205, 2020 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-31900019
15.
Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes.
J Neurogenet
; 23(3): 252-61, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19169923
16.
Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent.
Nucl Med Commun
; 30(4): 314-8, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19242386
17.
Classification of Patients with COPD on LAMA Monotherapy Using the GOLD Criteria: Analysis of a Claims-Linked Patient Survey Study.
Pulm Ther
; 5(2): 191-200, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32026409
18.
Predictors of Symptom Burden in Patients with COPD on LAMA Monotherapy: Multivariable Analysis of a Claims-Linked Survey Study.
Pulm Ther
; 5(2): 179-190, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-32026410
19.
Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study.
Pulm Ther
; 5(1): 69-80, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32026428
20.
Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study.
Int J Chron Obstruct Pulmon Dis
; 14: 1721-1737, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31534326